Sanofi
Sanofi Commits $1M to Support Parkinson's Disease Genetic Testing Study
The drugmaker has a small molecule drug called venglustat under Phase II development for Parkinson's disease patients with a specific genetic mutation.
In Brief This Week: Illumina, Novacyt, Twist Bioscience, iGene Laboratory, More
This week's news includes Illumina, Becton Dickinson, PerkinElmer, iGene Laboratory, Novacyt, Twist Bioscience, Lustgarten Foundation, and GlaxoSmithKline.
Sema4, Mount Sinai, Sanofi to Collaborate on Asthma Genomics Study
The researchers will combine genomic analysis with environmental and mobile device data from 1,200 participants to try to better understand the disease.
Sanofi Genzyme, PerkinElmer Launch Free Dx Program for Patients With Lysosomal Storage Disorders
The Lantern Project will screen for patients who may be suffering from Gaucher disease, Fabry disease, Pompe disease, MPS I, or ASMD, and offer confirmatory DNA testing.
Linguamatics' I2E natural language processing engine helps Sanofi match HLA alleles with multiple sclerosis and associated drug treatments.